Kekre N, Kim HT, Hofer J, Ho VT, et al. Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease. Bone Marrow Transplant 2020 Oct 12. pii: 10.1038/s41409-020-01083.
PMID: 33041331